0001104659-21-006035.txt : 20210121 0001104659-21-006035.hdr.sgml : 20210121 20210121060445 ACCESSION NUMBER: 0001104659-21-006035 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210121 DATE AS OF CHANGE: 20210121 EFFECTIVENESS DATE: 20210121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000910267 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-386912 FILM NUMBER: 21540296 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502444990 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0000910267 TITAN PHARMACEUTICALS INC 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA CALIFORNIA 94080 6502444990 DELAWARE None None Corporation true Marc Rubin 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA CALIFORNIA 94080 Executive Officer Katherine Beebe DeVarney 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA CALIFORNIA 94080 Executive Officer Director Joseph A. Akers 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA CALIFORNIA 94080 Director M. David McFarlane 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA CALIFORNIA 94080 Director James R. McNab, Jr. 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA CALIFORNIA 94080 Director Pharmaceuticals Decline to Disclose 06b false 2021-01-20 false true true false 0 9673750 9673750 0 false 7 0 677162 0 false TITAN PHARMACEUTICALS INC /s/ Kate Beebe DeVarney, Ph.D. Kate Beebe DeVarney, Ph.D. President and COO 2021-01-20